Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of nab-paclitaxel for desmoid tumors, desmoplastic small round cell tumors, and Ewing sarcoma
2016-002464-14Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Dec 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of nab-paclitaxel in aggressive fibromatosis (AF), desmoplastic small round cell tumor (DSRCT) and Ewing sarcoma (3 cohorts), sponsored by Spanish Group for Research on Sarcoma. Started Dec 2016; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
aggressive fibromatosis (AF)desmoplastic small round cell tumor (DSRCT)Ewing sarcoma
Beyond the preview
Go deeper on 2016-002464-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002464-14.